IPO mania fizzles in Hong Kong as mega first-day pops disappear


HONG KONG, March 20 (Bloomberg): The days of the massive first-day pop in Hong Kong’s initial public offering frenzy may be nearing an end.

Even as the pandemic spread for most of 2020, the offshore Chinese city’s IPOs and new listings were in hot demand from both institutional and mom-and-pop investors. With the bulk of new share sales posting large gains on their first-day of trading, investor euphoria was justified.

That was then. Last year’s largely winning investor play of piling into IPOs and exiting after they debuted is no longer a slam dunk: 31% of thirteen IPOs raising more than $100 million posted losses on day one this year, almost double the 17% in 2020. A median first-day move showed gains of 2.1% in 2021 from 5.7% last year, according to data compiled by Bloomberg.

Volatility sparked by the great rotation into previously unloved stocks sensitive to economic fluctuations from loftily valued tech and health-care plays is to blame, according to investors. Others also pointed to worries about policy being tightened in China as weighing on investors’ risk appetite for new stock.

"Most IPOs performed really, really strongly last year, but I’m not expecting that kind of movement this year,” said Joohee An, a fund manager at Mirae Asset Global Invest (HK) Ltd. Investors will be "more prudent” as market liquidity "won’t be as abundant as it used to be”, she added.

Hong Kong Bankers Work Around the Clock as IPOs, SPACs Surge (1)

Wobbly Performance

To be clear, listings by Kuaishou Technology and New Horizon Health Ltd. still did unusually well in February, with shares more than doubling on the first day.

But lukewarm post-listing performances are increasing. Chinese household insecticide company Cheerwin Group Ltd. slumped as much as 20% on its first trading day last week. Biopharmaceutical company SciClone Pharmaceuticals Holdings Ltd. ended its March 3 debut flat and is now trading 8.6% below its offer price.

The secondary listing wave of US-listed Chinese companies hasn’t always had glowing debuts in Hong Kong. Autohome Inc., a Chinese online car-sales website with its primary listing in New York, ended its Hong Kong debut on Monday with a modest 2% rise.

Not everyone is concerned, given rising concerns voiced by some that global markets were in bubble territory.

"When you have these deals that don’t do well, it actually tells you that people are still being cautious about what they’re investing in and what they’re not, which is a good sign,” said Sumeet Singh, head of research at Aequitas Research in Singapore, who publishes on Smartkarma. "It means the market is doing OK.”

Reality Check

The upcoming multi-billion dollar listings of Baidu Inc. and Bilibili Inc. will be closely watched to see if Hong Kong’s IPO market still has steam, given their size and high profile as tech companies.

Baidu, which priced at an almost 3% discount to its U.S.-traded shares, will start trading March 23. Investor demand for its offering was strong, with retail investors putting in orders for almost 100 times the stock made available to them, according to a person familiar with the matter. Bilibili, the video streaming platform that is looking to raise as much as $3.2 billion in a second listing, plans to debut on March 29.

"I am definitely not concerned,” said Oliver Cox, a top-performing fund manager at JP Morgan Asset Management, In general, "the quality and long-term earnings growth prospects of the companies we see coming to market is still very high indeed and pricing of IPOs does not affect that” he said. - Bloomberg
Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3

HK , Initial , IPO , Frenzy , Not So Great , Covid-19

   

Next In Aseanplus News

Vietnam agency seeks to build airport on disputed Spratly islands: media
S. Korea reports largest job growth in almost seven years in April
First two Covid-19 India variant cases in Philippines confirmed
Magnitude 5.8 quake hits south of Philippine capital, no damage expected
China's Sinovac Covid-19 vaccine found highly effective in real world study
1.8 million receive one dose
‘Double mutant’ strain fuelling India cases in Philippines
Asean preps next move as dialogue moves further out of reach
France rejects claims over Agent Orange
Thailand seeks ‘humanitarian’ solution for fleeing journos

Stories You'll Enjoy


Vouchers